Testing for specific proteins significantly improves sensitivity of stool-based colorectal cancer screening

Testing for novel protein biomarkers in stool finds significantly more colorectal cancers (CRC) and advanced adenomas (precursors to cancer) compared to testing for hemoglobin alone. The proteins can be detected in a small sample of the fecal immunochemical test (FIT), which suggests that they can be applied in population screening. The findings are published in Annals of Internal Medicine.

CRC screening can save lives by detecting cancer in its early stages when it is still treatable. Colonoscopy is the gold standard for detecting colorectal tumors, but the test is costly and invasive. As such, most population-wide screening programs use noninvasive stool-based tests, such as the FIT, for triage to colonoscopy. The FIT tests for hemoglobin, or blood protein, in the stool, however, its sensitivity for detecting CRC and advanced adenomas is suboptimal.

Researchers from the Netherlands Cancer Institute and VU University Medical Center sought to identify novel protein biomarkers in stool that could outperform or complement hemoglobin in detecting CRC and advanced adenomas. The researchers used mass spectrometry to search for proteins that were present in from persons with CRC or advanced adenomas, and which were virtually absent from stool specimens from controls. By using a combination of four novel protein biomarkers, in this study the investigators found that they were able to detect almost twice as many and 5 times as many advanced adenomas, compared to using alone.

According to the researchers, this new test has the potential to be easily integrated into population-wide screening programs upon successful clinical validation. Because it uses the same technology as the current standard stool-based , few adjustments to the screening program would be needed.

Explore further

Test could detect early colorecral cancer-causing genetic biomarkers with high sensitivity

More information: Annals of Internal Medicine (2017). annals.org/aim/article/doi/10.7326/M17-1068
Journal information: Annals of Internal Medicine

Citation: Testing for specific proteins significantly improves sensitivity of stool-based colorectal cancer screening (2017, November 20) retrieved 18 October 2021 from https://medicalxpress.com/news/2017-11-specific-proteins-significantly-sensitivity-stool-based.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors